Literature DB >> 9650918

Workgroup 3: transgenic and reconstitution models of prostate cancer.

J E Green1, N M Greenberg, C L Ashendel, J C Barrett, C Boone, R H Getzenberg, J Henkin, R Matusik, T J Janus, H I Scher.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9650918     DOI: 10.1002/(sici)1097-0045(19980615)36:1<59::aid-pros11>3.0.co;2-h

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


× No keyword cloud information.
  6 in total

1.  Application of Gleason analogous grading system and flow cytometry DNA analysis in a novel knock-in mouse prostate cancer model.

Authors:  G Wu; Lei Yu; L Wang; H Wang; J W Xuan
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

Review 2.  Modeling prostate cancer in mice: limitations and opportunities.

Authors:  Patrick J Hensley; Natasha Kyprianou
Journal:  J Androl       Date:  2011-06-16

3.  Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium.

Authors:  M Stanbrough; I Leav; P W Kwan; G J Bubley; S P Balk
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

4.  Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis.

Authors:  Minjung J Kim; Robert D Cardiff; Nishita Desai; Whitney A Banach-Petrosky; Ramon Parsons; Michael M Shen; Cory Abate-Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

5.  Molecular characterization of the Ggamma-globin-Tag transgenic mouse model of hormone refractory prostate cancer: comparison to human prostate cancer.

Authors:  Alfonso Calvo; Carlos Perez-Stable; Victor Segura; Raúl Catena; Elizabeth Guruceaga; Paul Nguewa; David Blanco; Luis Parada; Teresita Reiner; Jeffrey E Green
Journal:  Prostate       Date:  2010-05-01       Impact factor: 4.104

Review 6.  Inorganic arsenic and human prostate cancer.

Authors:  Lamia Benbrahim-Tallaa; Michael P Waalkes
Journal:  Environ Health Perspect       Date:  2008-02       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.